An additional £1m has been invested to keep an emergency care unit going at the Royal London Hospital.

“It can hit you out of nowhere,” she tells TODAY.com.

CRISPR gene therapy Casgevy can nearly eliminate sickle cell crises, but difficult stem‑cell collection is delaying access ...

If you or someone you know has sickle cell disease (SCD), you may have heard of Lyfgenia, one of two gene therapies approved for this condition. Gene therapies are the only treatments for SCD that can ...

Sickle cell disease is a lifelong condition that can cause severe pain episodes and frequent emergency department visits.

"The shutting down of units like this, adding to people's waiting time, adding to people's journey time, are the types of things that could definitely leave someone with sickle cell in a lot of pain, ...

Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...

Advocates stress that while gene therapy is causing a buzz in wealthy countries, African governments must prioritise ...

Three University High students have started the Caring Cells Project to raise awareness and provide care packages for ...